Isothermal Nucleic Acid Amplification Technology Market

Global INAAT Market Size (2023 to 2028)

The global market for isothermal nucleic acid amplification technology (INAAT) is expected to grow at a CAGR of 12% from 2023 to 2028 and be worth USD 2.88 billion in 2023 and USD 5.09 billion in 2028.

The recombinant DNA and molecular biology approach benefit from isothermal nucleic acid technologies. Small amounts of nucleic acids are detected and analyzed using these techniques. In addition, isothermal nucleic acid and amplification technologies are used in polymerase chain reactions. The polymerase chain reaction (PCR) is the most extensively used method for DNA amplification. The polymerase chain reaction (PCR) is a technique for detecting and identifying infectious diseases and genetic problems and doing research. The thermocycling equipment in PCR allows for the separation and amplification of DNA strands. This technique is often used to diagnose viral, genetic, and inherited disorders quickly, sensitively, and accurately using DNA, RNA, cells, proteins, tiny molecules, and ions.

Impact of COVID-19 on the global isothermal nucleic acid amplification technology market:

Pharmaceutical and biotech companies, in collaboration with governments throughout the world, are working to combat the COVID-19 outbreak, from vaccine research to planning for obstacles in the pharmaceutical supply chain. In addition, commonly used drugs such as hydroxychloroquine have witnessed a considerable surge in demand for COVID-19 treatment. Because many wealthy countries are running out of these treatments, the growing demand has presented a significant opportunity for COVID-19 management drug producers. Furthermore, the pharmaceutical and biotechnology industries are predicted to increase significantly due to the demand for COVID-19 vaccines and treatment medications. As a result, COVID-19 is likely to have a significant impact on the isothermal nucleic acid and amplification technology market due to these considerations.

MARKET DRIVERS:

Sales of isothermal nucleic acid amplification technologies and related services make up the isothermal nucleic acid amplification technology (INAAT) market. Only equipment manufacturers' installation and maintenance services are included in the offerings. At a constant temperature, isothermal nucleic acid amplification technologies amplify DNA sequences from two distinct nucleic acid segments. Continuous improvements in existing amplification products, as well as the introduction of new technologies such as Strand Displacement Amplification (SDA), Single Primer Isothermal Amplification (SPIA), and Recombinase Polymerase Amplification (RPA), as well as shifting regulatory scenarios, are expected to drive the market forward.

In addition, the isothermal nucleic acid amplification technology market is expected to gain significant growth opportunities in the projected years due to the extensive range of end-users. End-users such as reference laboratories, hospitals, physicians' offices, and clinics, academic and research institutes, donor banks, blood banks, IVD manufacturers, and community clinic laboratories are progressively using products from the isothermal nucleic acid amplification technology market. Furthermore, there has been a noticeable upsurge in several infectious health problems worldwide in recent years. Moreover, the advent of novel infections has increased the demand for quick identification of these diseases. These reasons boost the worldwide isothermal nucleic acid amplification technology market's growth opportunities.

MARKET RESTRAINTS:

Lack of awareness and lack of perfection about the introduction of advanced technologies and the expansion of polymerase chain reaction would function as a significant challenge for the market's growth. In addition, lengthy regulatory procedures limit the opportunity for additional research into the safety and efficacy of devices, affecting the vendors' operating cycles and, as a result, the market's growth.

REPORT COVERAGE:

This research report on the global isothermal nucleic acid amplification technology market has been segmented and sub-segmented based on the product, technology, end-user, and region.

Isothermal Nucleic Acid Amplification Technology Market – By Product:

• Instruments
• Reagents

Because of the increasing number of infectious disease diagnostic tests performed, the growing prevalence of infectious diseases, the continuous launch of newer, faster, and more reliable POC products, increasing approvals of CLIA-waived tests, accessibility to a wide range of reagents, repeated purchase of reagents, and the increasing use of reagents in therapeutics, reagents segment is projected to grow at the highest CAGR during the forecast period.

Isothermal Nucleic Acid Amplification Technology Market – By Technology:

• Helicase-dependent Amplification (HDA)
• Nicking Enzyme Amplification Reaction (NEAR)
• Loop-mediated Isothermal Amplification (LAMP)
• Strand Displacement Amplification (SDA)
• Nucleic Acid Sequence-based Amplification (NASBA)
• Transcription Mediated Amplification (TMA)

The most extensively utilized approach is loop-mediated isothermal amplification (LAMP), predicted to develop substantially over the forecast period. A minimum of four primers are used in this approach, two outer primers and two inside primers. Primers can be designed using a variety of applications, including primer explorer, LAMP Designer, and other programs. These loop primers bind to the nucleic acid template, speeding up the reaction. The method can be applied to both DNA and RNA amplification.

Isothermal Nucleic Acid Amplification Technology Market – By End-User:

• Hospitals
• Central and reference labs

Based on the end-user, the central and reference labs segment is predicted to demonstrate the highest growth in the global isothermal nucleic acid amplification technology market due to an increasing number of reference laboratories and significant use of novel & accurate novel & accurate molecular diagnostic procedures.

Isothermal Nucleic Acid Amplification Technology Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Geographically, North America is one of the significant regions expected to contribute significantly to the global isothermal nucleic acid amplification technology market growth during the forecast period. The healthcare industry's increased use of technologically enhanced diagnostics and blood screening technologies boosts the regional market growth. Furthermore, the growing number of genome-based medication research initiatives and a well-established healthcare system in the region drive the North American market. Because of established research infrastructure and expanding research programs, economies in the region, especially the United States and Canada, have experienced rapid growth. Therefore, the intense rivalry in the isothermal diagnostics market might be attributable to rising demand and investments from overseas firms.

The Asia Pacific is expected to be the fastest-growing region over the forecast period. Because of its robust economic expansion, China has seen considerable urbanization. The adoption of INAAT devices is expected to be driven by an increase in disposable money in developing nations, a large population, increased investments in healthcare facilities, and unmet clinical demands. The market is also likely to benefit from increased demand for cost-effective diagnosis and preventive medicine.

Due to increased product introductions in Europe, the global isothermal nucleic acid amplification technology (INAAT) market is likely to rise significantly.

KEY MARKET PLAYERS:

Companies playing a significant role in the global isothermal nucleic acid amplification technology market profiled in this report are Becton, Dickinson and Company, bioMerieux SA, Eiken Chemical Co., Ltd., Lucigen Corporation, Meridian Bioscience, Inc., Nugen Audio, QIAGEN GmbH, and Ustar Biotechnologies (Hangzhou) Ltd.

Recent Happenings in this Market:

• Aptima BV and Aptima CV/TV Molecular Assays from Hologic available in Europe in 2019.
• Quantabio Introduces Single-Tube Lyophilized Reagent in 2019 to Make RT-qPCR RNA Applications Shipping, Storage, and Setup Easier.
• KKR and Namal Nawana announced to development of Sapphiros, a Next-Generation Diagnostics Platform, in 2021.